103 related articles for article (PubMed ID: 22819074)
1. Overexpression of MDR1 and survivin, and decreased Bim expression mediate multidrug-resistance in multiple myeloma cells.
Tsubaki M; Satou T; Itoh T; Imano M; Komai M; Nishinobo M; Yamashita M; Yanae M; Yamazoe Y; Nishida S
Leuk Res; 2012 Oct; 36(10):1315-22. PubMed ID: 22819074
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of survivin via activation of ERK1/2, Akt, and NF-κB plays a central role in vincristine resistance in multiple myeloma cells.
Tsubaki M; Takeda T; Ogawa N; Sakamoto K; Shimaoka H; Fujita A; Itoh T; Imano M; Ishizaka T; Satou T; Nishida S
Leuk Res; 2015 Apr; 39(4):445-52. PubMed ID: 25726084
[TBL] [Abstract][Full Text] [Related]
3. By inhibiting Src, verapamil and dasatinib overcome multidrug resistance via increased expression of Bim and decreased expressions of MDR1 and survivin in human multidrug-resistant myeloma cells.
Tsubaki M; Komai M; Itoh T; Imano M; Sakamoto K; Shimaoka H; Takeda T; Ogawa N; Mashimo K; Fujiwara D; Mukai J; Sakaguchi K; Satou T; Nishida S
Leuk Res; 2014 Jan; 38(1):121-30. PubMed ID: 24239173
[TBL] [Abstract][Full Text] [Related]
4. The imbalance between Survivin and Bim mediates tumour growth and correlates with poor survival in patients with multiple myeloma.
Romagnoli M; Séveno C; Wuillème-Toumi S; Amiot M; Bataille R; Minvielle S; Barillé-Nion S
Br J Haematol; 2009 Apr; 145(2):180-9. PubMed ID: 19298592
[TBL] [Abstract][Full Text] [Related]
5. IAP family protein expression correlates with poor outcome of multiple myeloma patients in association with chemotherapy-induced overexpression of multidrug resistance genes.
Nakagawa Y; Abe S; Kurata M; Hasegawa M; Yamamoto K; Inoue M; Takemura T; Suzuki K; Kitagawa M
Am J Hematol; 2006 Nov; 81(11):824-31. PubMed ID: 16929535
[TBL] [Abstract][Full Text] [Related]
6. beta(2)-microglobulin induces apoptosis in HL-60 human leukemia cell line and its multidrug resistant variants overexpressing MRP1 but lacking Bax or overexpressing P-glycoprotein.
Wu CH; Rastegar M; Gordon J; Safa AR
Oncogene; 2001 Oct; 20(48):7006-20. PubMed ID: 11704825
[TBL] [Abstract][Full Text] [Related]
7. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
Shukla S; Rizvi F; Raisuddin S; Kakkar P
Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
[TBL] [Abstract][Full Text] [Related]
8. Severe combined immunodeficiency (SCID) mouse modeling of P-glycoprotein chemosensitization in multidrug-resistant human myeloma xenografts.
Bellamy WT; Odeleye A; Huizenga E; Dalton WS; Weinstein RS; Grogan TM
Clin Cancer Res; 1995 Dec; 1(12):1563-70. PubMed ID: 9815957
[TBL] [Abstract][Full Text] [Related]
9. Ribotoxic stress sensitizes glioblastoma cells to death receptor induced apoptosis: requirements for c-Jun NH2-terminal kinase and Bim.
Xia S; Li Y; Rosen EM; Laterra J
Mol Cancer Res; 2007 Aug; 5(8):783-92. PubMed ID: 17699104
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of HIF-1α contributes to melphalan resistance in multiple myeloma cells by activation of ERK1/2, Akt, and NF-κB.
Tsubaki M; Takeda T; Tomonari Y; Koumoto YI; Imano M; Satou T; Nishida S
Lab Invest; 2019 Jan; 99(1):72-84. PubMed ID: 30353128
[TBL] [Abstract][Full Text] [Related]
11. Melphalan-induced apoptosis in multiple myeloma cells is associated with a cleavage of Mcl-1 and Bim and a decrease in the Mcl-1/Bim complex.
Gomez-Bougie P; Oliver L; Le Gouill S; Bataille R; Amiot M
Oncogene; 2005 Dec; 24(54):8076-9. PubMed ID: 16091744
[TBL] [Abstract][Full Text] [Related]
12. Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: evidence for contribution to apoptosis resistance.
Zantl N; Weirich G; Zall H; Seiffert BM; Fischer SF; Kirschnek S; Hartmann C; Fritsch RM; Gillissen B; Daniel PT; Häcker G
Oncogene; 2007 Oct; 26(49):7038-48. PubMed ID: 17486061
[TBL] [Abstract][Full Text] [Related]
13. Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma.
Gomez-Bougie P; Wuillème-Toumi S; Ménoret E; Trichet V; Robillard N; Philippe M; Bataille R; Amiot M
Cancer Res; 2007 Jun; 67(11):5418-24. PubMed ID: 17545623
[TBL] [Abstract][Full Text] [Related]
14. Phenylarsine oxide induces apoptosis in Bax- and Bak-deficient cells through upregulation of Bim.
Ni B; Ma Q; Li B; Zhao L; Liu Y; Zhu Y; Chen Q
Clin Cancer Res; 2012 Jan; 18(1):140-51. PubMed ID: 22048238
[TBL] [Abstract][Full Text] [Related]
15. Resistance to the chemosensitizer verapamil in a multi-drug-resistant (MDR) human multiple myeloma cell line.
Abbaszadegan MR; Foley NE; Gleason-Guzman MC; Dalton WS
Int J Cancer; 1996 May; 66(4):506-14. PubMed ID: 8635866
[TBL] [Abstract][Full Text] [Related]
16. Calcitriol and its analogues enhance the antiproliferative activity of gefitinib in breast cancer cells.
Segovia-Mendoza M; Díaz L; González-González ME; Martínez-Reza I; García-Quiroz J; Prado-Garcia H; Ibarra-Sánchez MJ; Esparza-López J; Larrea F; García-Becerra R
J Steroid Biochem Mol Biol; 2015 Apr; 148():122-31. PubMed ID: 25510900
[TBL] [Abstract][Full Text] [Related]
17. [Role of dysregulation of Bim in resistance of melanoma cells to endoplasmic reticulum stress-induced apoptosis].
Hou LL; Jin L; Han CC; Cheng B; Wang L; Zhang XD; Zhang LJ
Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):494-8. PubMed ID: 22093624
[TBL] [Abstract][Full Text] [Related]
18. Reversal of MDR1 gene-dependent multidrug resistance in HL60/HT9 cells using short hairpin RNA expression vectors.
Shao SL; Zhang WW; Li XY; Zhang ZZ; Yun DZ; Fu B; Zuo MX
Cancer Biother Radiopharm; 2010 Apr; 25(2):171-7. PubMed ID: 20423230
[TBL] [Abstract][Full Text] [Related]
19. FGFR4 signaling couples to Bim and not Bmf to discriminate subsets of alveolar rhabdomyosarcoma cells.
Wachtel M; Rakic J; Okoniewski M; Bode P; Niggli F; Schäfer BW
Int J Cancer; 2014 Oct; 135(7):1543-52. PubMed ID: 24550147
[TBL] [Abstract][Full Text] [Related]
20. Bim downregulation by activation of NF-κB p65, Akt, and ERK1/2 is associated with adriamycin and dexamethasone resistance in multiple myeloma cells.
Tsubaki M; Takeda T; Matsuda T; Kishimoto K; Tanaka R; Tsurushima K; Ishizaka T; Nishida S
Clin Exp Med; 2023 Sep; 23(5):1597-1607. PubMed ID: 36451049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
